Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Colorectal Adenocarcinomas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00030524
What this trial is testing

ZD 1839 in Treating Patients With Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
The University of Texas Health Science Center at San Antonio
Testing effectiveness (Phase 2)Study completedNCT00336960
What this trial is testing

Celecoxib, Fluorouracil, and Radiation Therapy in Treating Patients With Stage II or Stage III Rectal Cancer That Can Be Removed By Surgery

Who this might be right for
Colorectal Cancer
Vanderbilt-Ingram Cancer Center 24
Early research (Phase 1)Study completedNCT00507091
What this trial is testing

Phase I Irinotecan, 5-Fluorouracil and Leucovorin Combination

Who this might be right for
MetastaticColorectalAdenocarcinoma
Genzyme, a Sanofi Company 24
Not applicableStudy completedNCT00097578
What this trial is testing

Avastin With Chemotherapy for Treatment of Metastatic or Advanced and Unresectable Colorectal Adenocarcinoma

Who this might be right for
Colorectal Cancer
Genentech, Inc. 1,953
Not applicableTemporarily pausedNCT04955808
What this trial is testing

Biospecimen Collection in Identifying Genetic Changes in Patients With Breast, Prostate, Colorectal, Liver, or Kidney Cancer or Multiple Myeloma Undergoing Surgery

Who this might be right for
Breast CarcinomaColon CarcinomaInvasive Carcinoma+5 more
National Cancer Institute (NCI) 2,400
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Not applicableNot Yet RecruitingNCT07191548
What this trial is testing

International Study on Treatment of Patients With Metastatic Colorectal Liver Lesions Patients With IRE

Who this might be right for
Colorectal Adenocarcinoma Metastatic in the LiverLiver AblationLiver Cancer, Adult
Angiodynamics, Inc. 50
Not applicableStudy completedNCT04316078
What this trial is testing

A Novel Patient Engagement Platform Among Patients With Gastrointestinal Malignancies

Who this might be right for
Colon CancerGastric CancerPancreas Cancer+4 more
Sheba Medical Center 126
Testing effectiveness (Phase 2)Study completedNCT03801915
What this trial is testing

Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers

Who this might be right for
Colon CancerPancreatic CancerCholangiocarcinoma+2 more
National Cancer Institute (NCI) 10
Early research (Phase 1)Active Not RecruitingNCT03170960
What this trial is testing

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Urothelial CarcinomaRenal Cell CarcinomaNon-Small Cell Lung Cancer+11 more
Exelixis 914
Testing effectiveness (Phase 2)UnknownNCT04475159
What this trial is testing

Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial

Who this might be right for
Metastatic Colorectal CancerPeritoneal CarcinomatosisColon Adenocarcinoma
Prof. Aviram Nissan 50
Testing effectiveness (Phase 2)Ended earlyNCT04177602
What this trial is testing

Evaluating Trifluridine/Tipiracil Based Chemoradiation in Locally Advanced Rectal Cancer - The Phase I/II TARC Trial

Who this might be right for
Locally Advanced Rectal Cancer
Universitätsklinikum Hamburg-Eppendorf 10
Early research (Phase 1)Study completedNCT03373188
What this trial is testing

VX15/2503 and Immunotherapy in Resectable Pancreatic and Colorectal Cancer

Who this might be right for
Colon Carcinoma Metastatic in the LiverColorectal AdenocarcinomaPancreatic Adenocarcinoma+11 more
Emory University 10
Testing effectiveness (Phase 2)Study completedNCT02368886
What this trial is testing

Lower or Standard Dose Regorafenib in Treating Patients With Refractory Metastatic Colorectal Cancer

Who this might be right for
Colon AdenocarcinomaRectal AdenocarcinomaStage III Colorectal Cancer AJCC v7+6 more
Academic and Community Cancer Research United 123
Testing effectiveness (Phase 2)UnknownNCT03992456
What this trial is testing

Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer

Who this might be right for
Metastatic Colon AdenocarcinomaMetastatic Colorectal CarcinomaMetastatic Rectal Adenocarcinoma+27 more
Academic and Community Cancer Research United 12
Not applicableStudy completedNCT05280379
What this trial is testing

Trained Immunity in Thyroid Carcinoma and Colon Carcinoma

Who this might be right for
Thyroid Cancer, NonmedullaryColon Carcinoma
Radboud University Medical Center 33
Testing effectiveness (Phase 2)UnknownNCT02528526
What this trial is testing

Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm

Who this might be right for
Pancreatic NeoplasmsHepatocellular CancerCholangiocarcinoma+1 more
University of Zurich 69
Testing effectiveness (Phase 2)Looking for participantsNCT06047379
What this trial is testing

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Who this might be right for
Diffuse Astrocytoma, IDH-MutantGlioblastoma, IDH-wildtypeBrain Metastases, Adult+18 more
Neonc Technologies, Inc. 134
Early research (Phase 1)Active Not RecruitingNCT04704661
What this trial is testing

Testing the Combination of Two Anti-cancer Drugs, DS-8201a and AZD6738, for The Treatment of Advanced Solid Tumors Expressing the HER2 Protein or Gene, The DASH Trial

Who this might be right for
Advanced Breast CarcinomaAdvanced Colon CarcinomaAdvanced Colorectal Carcinoma+37 more
National Cancer Institute (NCI) 51
Testing effectiveness (Phase 2)Looking for participantsNCT05672524
What this trial is testing

Tucatinib and Trastuzumab in People With Rectal Cancer

Who this might be right for
Adenocarcinoma of the RectumLocally Advanced Rectal AdenocarcinomaRectal Adenocarcinoma+2 more
Memorial Sloan Kettering Cancer Center 37
Next Page